Difference between revisions of "Vinson Pharmaceuticals"

m (some cleanup)
Line 1: Line 1:
'''Name:''' Vinson Pharmaceuticals
+
'''Vinson Pharmaceuticals''' is a Pharmacy company in the [[Federated Suns]].
  
 +
==Company Profile==
 
'''New Avalon Stock & Commodities Symbol:''' VnPh
 
'''New Avalon Stock & Commodities Symbol:''' VnPh
  
 
'''Home Office Location:''' Kiverson City, [[Torrence]]
 
'''Home Office Location:''' Kiverson City, [[Torrence]]
  
'''President/CEO:''' (3025) Baroness Marth Terenson
+
'''President/CEO:''' Baroness Marth Terenson (3025)
  
'''Business Profile:'''
+
==Overview==
In mid 3025 Vinson Pharmaceuticals moved to stop from being nationalized by the Torrence's newly elected socialist government. The company was successfully able to find off world investors to buy a minimum of 40 percent of the company’s securities. This move prevented Vinson from becoming nationalized. The company was well known for its pharmacological abilities. In the early 3020's Vinson was able to isolate the agents in old folk remedies such as herbal teas or homeopathic mixtures. They then were able to produce strong synthetic duplicates that could be used in painkillers. In early  3025 the [[Armed Forces of the Federated Suns|Davion]] military had acquired exclusive right to buy 100% of the companies output.
+
In mid 3025 Vinson Pharmaceuticals moved to stop from being nationalized by the Torrence's newly elected socialist government. The company was successfully able to find off world investors to buy a minimum of 40 percent of the company’s securities. This move prevented Vinson from becoming nationalized. The company was well known for its pharmacological abilities. In the early 3020's Vinson was able to isolate the agents in old folk remedies such as herbal teas or homeopathic mixtures. They then were able to produce strong synthetic duplicates that could be used in painkillers. In early  3025 the [[Armed Forces of the Federated Suns|Davion]] military had acquired exclusive right to buy 100% of the companies output.<ref name=HDp173>''House Davion (The Federated Suns)'', p. 173, "Vinson PPharmaceuticals"</ref>
  
In 3049 the Torrence government against attempt to nationalize the company. The Baroness, now in her early 70's, was able to persuade the [[First Prince]] to personally get involved.
+
In 3049 the Torrence government against attempt to nationalize the company. The Baroness, now in her early 70's, was able to persuade the [[First Prince]] to personally get involved.{{cn}}
 +
 
 +
==References==
 +
<references/>
  
 
==Bibliography==
 
==Bibliography==
 
*''[[House Davion (The Federated Suns)]]''
 
*''[[House Davion (The Federated Suns)]]''
  
 
+
[[Category:Companies|Vinson Pharmaceuticals]]
 
[[Category:Manufacturing Centers|Vinson Pharmaceuticals]]
 
[[Category:Manufacturing Centers|Vinson Pharmaceuticals]]

Revision as of 19:12, 23 July 2012

Vinson Pharmaceuticals is a Pharmacy company in the Federated Suns.

Company Profile

New Avalon Stock & Commodities Symbol: VnPh

Home Office Location: Kiverson City, Torrence

President/CEO: Baroness Marth Terenson (3025)

Overview

In mid 3025 Vinson Pharmaceuticals moved to stop from being nationalized by the Torrence's newly elected socialist government. The company was successfully able to find off world investors to buy a minimum of 40 percent of the company’s securities. This move prevented Vinson from becoming nationalized. The company was well known for its pharmacological abilities. In the early 3020's Vinson was able to isolate the agents in old folk remedies such as herbal teas or homeopathic mixtures. They then were able to produce strong synthetic duplicates that could be used in painkillers. In early 3025 the Davion military had acquired exclusive right to buy 100% of the companies output.[1]

In 3049 the Torrence government against attempt to nationalize the company. The Baroness, now in her early 70's, was able to persuade the First Prince to personally get involved.[citation needed]

References

  1. House Davion (The Federated Suns), p. 173, "Vinson PPharmaceuticals"

Bibliography